Connect Biopharma Holdings Limited Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets
Connect Biopharma Holdings Limited (CNTB) reported Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets of $11.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementAssets · last filed 2024-09-05
CNY
| Period end | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets 6 month | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets 12 month |
|---|---|---|
| 2023-06-30 | 1.53M CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | -2.51M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | -1.31M CNY 6-K · filed 2023-09-12 |
USD
| Period end | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets 6 month | Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Assets 12 month |
|---|---|---|
| 2024-06-30 | $11.00K 6-K · filed 2024-09-05 | |
| 2023-12-31 | $354.00K 20-F · filed 2024-04-16 | |
| 2023-06-30 | $222.00K 6-K · filed 2024-09-05 | |
| 2022-12-31 | -$365.00K 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |